Evidence map›Paper›PMID 33772594›Full record

ArticleNucleic acids research2021

What defines a synthetic riboswitch? - Conformational dynamics of ciprofloxacin aptamers with similar binding affinities but varying regulatory potentials.

Christoph Kaiser, Jeannine Schneider, Florian Groher, Beatrix Suess, Josef Wachtveitl

Open access · goldAbstract read
In one paragraph

Article in Nucleic acids research, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.7field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 13 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Regulatory RNAs inSynthetic and systems biotechnology · 2024
    Review
  8. RNA folding kinetics control riboswitch sensitivity in vivo.bioRxiv : the preprint server for biology · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Christoph KaiserInstitute for Physical and Theoretical Chemistry, Goethe-Universität Frankfurt, Max-von-Laue-Straße 8, D-60438 Frankfurt am Main, Germany.
Jeannine SchneiderDepartment of Biology, Technische Universität Darmstadt, Schnittspahnstraße 10, D-64287 Darmstadt, Germany.
Florian GroherDepartment of Biology, Technische Universität Darmstadt, Schnittspahnstraße 10, D-64287 Darmstadt, Germany.
Beatrix SuessDepartment of Biology, Technische Universität Darmstadt, Schnittspahnstraße 10, D-64287 Darmstadt, Germany.
Josef WachtveitlInstitute for Physical and Theoretical Chemistry, Goethe-Universität Frankfurt, Max-von-Laue-Straße 8, D-60438 Frankfurt am Main, Germany.
Technische Universität Darmstadt · DEGoethe University Frankfurt · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Among the many in vitro-selected aptamers derived from SELEX protocols, only a small fraction has the potential to be applied for synthetic riboswitch engineering. Here, we present a comparative study of the binding properties of three different aptamers that bind to ciprofloxacin with similar KD values, yet only two of them can be applied as riboswitches. We used the inherent ligand fluorescence that is quenched upon binding as the reporter signal in fluorescence titration and in time-resolved stopped-flow experiments. Thus, we were able to demonstrate differences in the binding kinetics of regulating and non-regulating aptamers. All aptamers studied underwent a two-step binding mechanism that suggests an initial association step followed by a reorganization of the aptamer to accommodate the ligand. We show that increasing regulatory potential is correlated with a decreasing back-reaction rate of the second binding step, thus resulting in a virtually irreversible last binding step of regulating aptamers. We suggest that a highly favoured structural adaption of the RNA to the ligand during the final binding step is essential for turning an aptamer into a riboswitch. In addition, our results provide an explanation for the fact that so few aptamers with regulating capacity have been found to date. Based on our data, we propose an adjustment of the selection protocol for efficient riboswitch detection.

Indexed as

RiboswitchAptamers, NucleotideCiprofloxacinLigandsNucleic Acid ConformationRNASELEX Aptamer TechniqueAptamers, NucleotideCiprofloxacinLigandsRiboswitchRNA

Identifiers

PMID33772594
PMCPMC8053125
OpenAlexW3151547568

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.